The authors' reply

Affiliations

¹ 1 University of Alabama at Birmingham Comprehensive Transplant Institute Birmingham, ALa 2 Johns Hopkins University Comprehensive Transplant Center Baltimore, MD.

Comment

Jayme E Locke et al. Transplantation. 2014.

. 2014 Jun 27;97(12):e70-1.

doi: 10.1097/TP.0000000000000193.

¹ 1 University of Alabama at Birmingham Comprehensive Transplant Institute Birmingham, ALa 2 Johns Hopkins University Comprehensive Transplant Center Baltimore, MD.

No abstract available

Comment on

Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.
Locke JE, James NT, Mannon RB, Mehta SG, Pappas PG, Baddley JW, Desai NM, Montgomery RA, Segev DL. Locke JE, et al. Transplantation. 2014 Feb 27;97(4):446-50. doi: 10.1097/01.TP.0000436905.54640.8c. Transplantation. 2014. PMID: 24162248
Optimal immunosuppression for HIV-positive kidney transplants: long-term randomized controlled trials needed.
Nazarian SM, Misch EA, Rakita RM, Limaye AP. Nazarian SM, et al. Transplantation. 2014 Jun 27;97(12):e70. doi: 10.1097/TP.0000000000000192. Transplantation. 2014. PMID: 24933252 No abstract available.